Healthcare provider profile · identity verified

German Suarez, MD

Internal Medicine · MIAMI, FL · NPI 1134139496

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	844	250
Metformin Hcl	Metformin Hcl	391	117
Rosuvastatin Calcium	Rosuvastatin Calcium	385	132
Levothyroxine Sodium	Levothyroxine Sodium	336	99
Amlodipine Besylate	Amlodipine Besylate	333	108
Losartan Potassium	Losartan Potassium	296	97
Lisinopril	Lisinopril	243	75
Pantoprazole Sodium	Pantoprazole Sodium	237	89
Famotidine	Famotidine	225	74
Metoprolol Succinate	Metoprolol Succinate	217	61
Fluticasone Propionate	Fluticasone Propionate	196	75
Omeprazole	Omeprazole	182	68
Hydrochlorothiazide	Hydrochlorothiazide	181	61
Clopidogrel	Clopidogrel Bisulfate	142	42
Glimepiride	Glimepiride	141	35
Tamsulosin Hcl	Tamsulosin Hcl	124	49
Alendronate Sodium	Alendronate Sodium	121	40
Escitalopram Oxalate	Escitalopram Oxalate	120	38
Montelukast Sodium	Montelukast Sodium	120	37
Gabapentin	Gabapentin	119	45
Eliquis	Apixaban	114	29
Albuterol Sulfate Hfa	Albuterol Sulfate	94	27
Simvastatin	Simvastatin	92	31
Atenolol	Atenolol	91	25
Carvedilol	Carvedilol	89	27
Metoprolol Tartrate	Metoprolol Tartrate	77	26
Ezetimibe	Ezetimibe	73	27
Furosemide	Furosemide	71	23
Valsartan	Valsartan	67	24
Enalapril Maleate	Enalapril Maleate	66	20
Mirtazapine	Mirtazapine	66	17
Allopurinol	Allopurinol	65	22
Lantus	Insulin Glargine,hum.Rec.Anlog	65	13
Diclofenac Sodium	Diclofenac Sodium	64	20
Glipizide	Glipizide	63	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	26
Nifedipine Er	Nifedipine	51	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	suppressed
Sildenafil Citrate	Sildenafil Citrate	49	11
Symbicort	Budesonide/Formoterol Fumarate	49	15
Trazodone Hcl	Trazodone Hcl	49	18
Hydralazine Hcl	Hydralazine Hcl	48	12
Ketoconazole	Ketoconazole	48	17
Labetalol Hcl	Labetalol Hcl	48	16
Latanoprost	Latanoprost	47	13
Clotrimazole	Clotrimazole	45	23
Glipizide Er	Glipizide	45	13
Sertraline Hcl	Sertraline Hcl	44	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	43	14
Meclizine Hcl	Meclizine Hcl	42	15
Clonidine Hcl	Clonidine Hcl	41	14
Duloxetine Hcl	Duloxetine Hcl	40	17
Esomeprazole Magnesium	Esomeprazole Magnesium	40	15
Metformin Hcl Er	Metformin Hcl	40	12
Pravastatin Sodium	Pravastatin Sodium	40	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	18
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Pentoxifylline	Pentoxifylline	35	11
Ammonium Lactate	Ammonium Lactate	34	12
Folic Acid	Folic Acid	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	28
Farxiga	Dapagliflozin Propanediol	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Azithromycin	Azithromycin	28	26
Irbesartan	Irbesartan	28	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Mupirocin	Mupirocin	28	24
Novolog Flexpen	Insulin Aspart	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	15
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Breyna	Budesonide/Formoterol Fumarate	26	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	26	suppressed
Lactulose	Lactulose	25	15
Memantine Hcl	Memantine Hcl	25	12
Synthroid	Levothyroxine Sodium	25	11
Bumetanide	Bumetanide	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	24	suppressed
Ozempic	Semaglutide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Finasteride	Finasteride	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Ramipril	Ramipril	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Ciclopirox	Ciclopirox	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Celecoxib	Celecoxib	16	13
Ciclopirox	Ciclopirox Olamine	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Clonidine	Clonidine	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Constulose	Lactulose	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Prednisone	Prednisone	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error